GluN2A NMDA Receptor Enhancement Improves Brain Oscillations, Synchrony, and Cognitive Functions in Dravet Syndrome and Alzheimer’s Disease Models

Autor: Hilda Solanoy, Morgan Sheng, Gui-Qiu Yu, Jesse E. Hanson, Gauri Deshmukh, Benjamin D. Sellers, Tzu-Ming Wang, Yelin Chen, Justin Elstrott, Connie Chan, Zhiyu Jiang, Thomas A. Kim, David H. Hackos, Jacob Schwarz, Jorge J. Palop, T. Michael Gill, Matthew Volgraf, Keran Ma, Jeffrey Simms, Kimberly Scearce-Levie, Martin Weber, Bianca M. Liederer, Sandrine Saillet, Abdullah S. Khan, Robby M. Weimer, Benjamin Liu
Jazyk: angličtina
Rok vydání: 2020
Předmět:
0301 basic medicine
Cyclopropanes
Male
Aging
Medical Physiology
Epilepsies
Myoclonic

Electroencephalography
Epilepsies
Neurodegenerative
Inbred C57BL
Alzheimer's Disease
memory
Epilepsy
Mice
0302 clinical medicine
Cognition
Receptors
2.1 Biological and endogenous factors
EEG
SCN1A
Aetiology
lcsh:QH301-705.5
MK-801
learning
Behavior
Animal

medicine.diagnostic_test
musculoskeletal
neural
and ocular physiology

Brain
medicine.anatomical_structure
Neurological
NMDA receptor
Mental health
N-Methyl-D-Aspartate
Allosteric modulator
Interneuron
Intellectual and Developmental Disabilities (IDD)
Allosteric regulation
CHO Cells
interneuron
Receptors
N-Methyl-D-Aspartate

Article
General Biochemistry
Genetics and Molecular Biology

03 medical and health sciences
Cricetulus
Dravet syndrome
Allosteric Regulation
Alzheimer Disease
Nitriles
Behavioral and Social Science
medicine
Acquired Cognitive Impairment
Animals
Humans
Behavior
business.industry
Animal
Nav1.1
Neurosciences
Alzheimer's Disease including Alzheimer's Disease Related Dementias (AD/ADRD)
medicine.disease
Brain Disorders
Mice
Inbred C57BL

Disease Models
Animal

Thiazoles
030104 developmental biology
nervous system
lcsh:Biology (General)
Disease Models
Pyrazoles
epilepsy
Dementia
Biochemistry and Cell Biology
J20
business
Myoclonic
APP
Neuroscience
030217 neurology & neurosurgery
Zdroj: Cell Reports, Vol 30, Iss 2, Pp 381-396.e4 (2020)
Elsevier
Cell reports, vol 30, iss 2
Cell reports
ISSN: 2211-1247
Popis: SUMMARY NMDA receptors (NMDARs) play subunit-specific roles in synaptic function and are implicated in neuropsychiatric and neurodegenerative disorders. However, the in vivo consequences and therapeutic potential of pharmacologically enhancing NMDAR function via allosteric modulation are largely un-known. We examine the in vivo effects of GNE-0723, a positive allosteric modulator of GluN2A-subunit-containing NMDARs, on brain network and cognitive functions in mouse models of Dravet syndrome (DS) and Alzheimer’s disease (AD). GNE-0723 use dependently potentiates synaptic NMDA receptor currents and reduces brain oscillation power with a predominant effect on low-frequency (12–20 Hz) oscillations. Interestingly, DS and AD mouse models display aberrant low-frequency oscillatory power that is tightly correlated with network hypersynchrony. GNE-0723 treatment reduces aberrant low-frequency oscillations and epileptiform discharges and improves cognitive functions in DS and AD mouse models. GluN2A-subunit-containing NMDAR enhancers may have therapeutic benefits in brain disorders with network hypersynchrony and cognitive impairments.
Graphical Abstract
In Brief Hanson et al. examine the therapeutic effects of enhancing GluN2A-subunit-containing NMDAR function in Dravet syndrome and Alzheimer’s disease mice. GNE-0723 treatment reduces aberrant low-frequency oscillations and epileptiform discharges and improves cognitive functions in both disease models. GluN2A NMDAR enhancers may benefit brain disorders with network hypersynchrony and cognitive impairments.
Databáze: OpenAIRE